Skip to content
News
Menu
News
Home
About
The Science
Preclinical Studies
Pipeline
Strong Patent Portfolio
Future Applications
Leadership
Management & Board of Directors
Advisory Board Members
Scientific Advisors
Publications
Contact
Menu
Home
About
The Science
Preclinical Studies
Pipeline
Strong Patent Portfolio
Future Applications
Leadership
Management & Board of Directors
Advisory Board Members
Scientific Advisors
Publications
Contact
World-class leadership team
Advisory Board Members
Roy S. Herbst
Advisory Board Member
See bio
Scott A. Levitt
Advisory Board Member
See bio
Marc K. Siegel, MD, FACP
Advisory Board Member
See bio
David J. Kerr
Advisory Board Member
See bio
Gregory C. Simon
Advisory Board Member
See bio
Close
Roy S. Herbst
Deputy director for clinical affairs and chief of oncology for Yale Cancer Center and Smilow Cancer Hospital
Ensign professor of medicine and assistant dean for translational research at Yale School of Medicine
Principal investigator for numerous clinical trials leading to the approval of several therapies that revolutionized the field (gefitinib, cetuximab, bevacizumab, axitinib, atezolizumab, and pembrolizumab)
Prominent figure in public policy having served on the National Academy of Medicine’s Cancer Policy
Authored or co-authored more than 350 publications
Chair for institutional review board of nationwide cancer practice
Professor of translational molecular biology
Clinical practice of internal medicine and infectious diseases
Close
Scott A. Levitt
10+ years of experience in healthcare finance focused on biotechnology, pharmaceuticals, medical devices, life science tools and diagnostics
Vice President at Pharmakon Advisors, the largest life science debt investor, which has committed >$7.5bn across 50+ companies
Healthcare Equity Research Associate at Evercore ISI
Investment banker at boutique life science bank focused on M&A, private placements, and venture capital
B.S.E. in Bioengineering and Engineering Entrepreneurship from the University of Pennsylvania
Close
Marc K. Siegel, MD, FACP
Clinical professor of medicine at NYU Langone
Medical director of Doctor Radio (on Sirius XM)
Fox News medical analyst. He has recently interviewed all the top US health officials including CDC, NIH, FDA, andHHS directors, as well as a sitting president, former president, and vice president
Author of 6 books, most recently COVID: the Politics of Fear and the Power of Science
Member of the board of contributors at USA Today and a columnist for TheHill, The Wall Street Journal, and the New York Post
Sponsorships/charitable contributions by Eli Lilly, the American Heart Association, and Novartis
Close
David J. Kerr
Rhodes Professor of clinical pharmacologyand Cancer Therapeuticsand Head of the Department of Clinical Pharmacology at the University of Oxford
Fellow of the Academy of Medical Sciences
President of the European Society of Medical Oncology
Director of NTRAC(National Translational Cancer Research Network)
Established the first network of top cancer centers in India
Organized the first ever African Cancer Reform convention in London
Advised a number of governments on their cancer strategy
Close
Gregory C. Simon
Executive Director Cancer Moonshot Task Force
President of the Biden Cancer initiative
Co-founder of Fastercures with Milken Institute and the Melanoma Research Alliance
Chief Domestic Policy Advisor under Vice President Al Gore
Member of Google Health Advisory Counsel
Sr. Vice PresidentWorldwide Policy and Patient Engagement for Pfizer